07:59 AM EDT, 09/12/2025 (MT Newswires) -- Anebulo Pharmaceuticals ( ANEB ) said Friday it received inbound interest from potential financial and strategic partners after it announced a going-private transaction earlier this year.

The clinical-stage biopharmaceutical company said its board will evaluate review all strategic alternatives, including the proposed going-private transaction and related reverse stock split.

In the meantime, Anebulo said it intends to proceeds with holding a special stockholder meeting to approve the proposed reverse stock split.

The company's shares were up 18% in recent premarket activity.